EXPRESS SCRIPTS, INC. for EXPRESS SCRIPTS, INC.

Defense DEF

Pharmacy issues related to the annual defense reauthorization.

Contacted: Executive Office of the President (EOP); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); White House Office; Labor, Dept of (DOL); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Office of Personnel Management (OPM); Government Accountability Office (GAO); SENATE; Centers For Medicare and Medicaid Services (CMS)

Taxation/Internal Revenue Code TAX

Regulatory implementation of various tax provisions in the health reform law, including the health insurer tax (HR 928/ S 183).

Contacted: Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Congressional Budget Office (CBO); White House Office; Labor, Dept of (DOL); Executive Office of the President (EOP); SENATE; Federal Trade Commission (FTC); Internal Revenue Service (IRS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Personnel Management (OPM)

Bills named: H.R. 928 (114th)

Health Issues HCR

Regulatory policies related to the health reform law: structure, drug benefits, disclosure. Regulatory implementation of HITECH/accounting of disclosures. Issues regarding making prescription drugs more affordable. Restrictions on specialty tiering.

Contacted: SENATE; Federal Trade Commission (FTC); Congressional Budget Office (CBO); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Office of Personnel Management (OPM); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Internal Revenue Service (IRS); White House Office; Health & Human Services, Dept of (HHS); Executive Office of the President (EOP)

Postal POS

Postal reform proposals, including rate reform, and their impact on 6 day mail delivery.

Contacted: Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Health Resources & Services Administration (HRSA); Labor, Dept of (DOL); SENATE; Congressional Budget Office (CBO); Internal Revenue Service (IRS); Office of Personnel Management (OPM); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); White House Office; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Health reform proposals that impact Medicare Part D such as formulary requirements, PBM disclosure provisions, closing of the Part D coverage gap. General Legislative and regulatory issues such as direct negotiation. Statutory implementation of changes to the definition of AMP in Medicaid. Exclusion of specialty distributors prompt pay discounts from the definition of average sales prices. Medicare audit and preferred network restrictions. HR 244; HR 793.

Contacted: SENATE; Health & Human Services, Dept of (HHS); Internal Revenue Service (IRS); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Federal Trade Commission (FTC); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA); Medicare Payment Advisory Commission (MedPAC); Labor, Dept of (DOL); Office of Personnel Management (OPM); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Congressional Budget Office (CBO); White House Office

Bills named: H.R. 244 (114th), H.R. 793 (114th)

Pharmacy PHA

Regulatory design and coverage of pharmacy benefits in health reform Exchanges and the commercial market, including: EHB, grandfathering, Rx quality, eRx, PBM disclosure, MLR, specialty pharmacy tiering restrictions. Regulatory implementation of a pathway for the approval of biosimilars. REMs. 340b program reform. policies placing restrictions on pharmacy benefit design. Issues regarding making prescription drugs more affordable, including: generic user fees, pedigree, biosimilars, REMs. General issues dealing with prescription drug abuse, including Medicare lock-in programs. General issues dealing with regulating pharmacy drug compounding. HR 1600; S 1190/ HR793.

Contacted: Health Resources & Services Administration (HRSA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Federal Trade Commission (FTC); Government Accountability Office (GAO); Internal Revenue Service (IRS); White House Office; Executive Office of the President (EOP); Office of Personnel Management (OPM); Congressional Budget Office (CBO); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; Labor, Dept of (DOL)

Bills named: H.R. 793 (114th), H.R. 1600 (114th)